Skip to main content
Erschienen in:

31.05.2017 | Pulmonology in Combat Medicine (G. Eapen, Section Editor)

Tobacco Cessation in the Military

verfasst von: Tyson J. Sjulin, Jackie A. Hayes, Deborah E. Bray

Erschienen in: Current Pulmonology Reports | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

The use of tobacco products in the military is higher than in the civilian population. Tobacco use is a major cause of morbidity and mortality and a major risk factor for many illnesses to include respiratory disease, cardiovascular disease, and malignancies. The use of tobacco products has also been associated with decreased physical fitness and higher attrition from military service. In veterans, there is an increased level of tobacco-related illnesses and potentially higher health care costs.

Recent Findings

The Department of Defense (DoD) continues to modify its tobacco use policies and limit tobacco use. There is an emphasis on education to prevent tobacco use and tobacco cessation programs to assist service members in quitting. Tobacco cessation efforts in the military are similar to those used in the civilian population but service members have unique challenges.

Summary

Tobacco use in the military continues to be higher than in the general population and continues to be a concern for military readiness. Tobacco cessation is associated with decreased incidence of tobacco related disease and prolonged lifespans. Tobacco use in the military is declining but more needs to be done.
Literatur
1.
Zurück zum Zitat Walter Reed Army Medical Center. Brief history of tobacco use and abuse. Walter Reed Army Medical Center. Brief history of tobacco use and abuse.
3.
Zurück zum Zitat Joseph AM, Muggli M, Pearson KC, Lando H. The cigarette to manufacturers’ effort to promote tobacco to the US military. Mil Med. 1970:874–80. Joseph AM, Muggli M, Pearson KC, Lando H. The cigarette to manufacturers’ effort to promote tobacco to the US military. Mil Med. 1970:874–80.
4.
Zurück zum Zitat Bachman JG, Freedman-Doan P, O’Malley P, Johnston LD, Segal DR. Changing patterns of drug use among US military recruits before and after enlistment. Am J Public Health. 1999;89(5):672–780.CrossRefPubMedPubMedCentral Bachman JG, Freedman-Doan P, O’Malley P, Johnston LD, Segal DR. Changing patterns of drug use among US military recruits before and after enlistment. Am J Public Health. 1999;89(5):672–780.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Zadoo V, Fengler S, Catterson M. The effects of alcohol and tobacco use on troop readiness. Mil Med. 1993;158:480–4.PubMed Zadoo V, Fengler S, Catterson M. The effects of alcohol and tobacco use on troop readiness. Mil Med. 1993;158:480–4.PubMed
6.
Zurück zum Zitat Bahrke MS, Baur TS, Poland DR, Connors DR. Tobacco use and performance on the US Army physical fitness test. Mil Med. 1998;153:229–35. Bahrke MS, Baur TS, Poland DR, Connors DR. Tobacco use and performance on the US Army physical fitness test. Mil Med. 1998;153:229–35.
7.
Zurück zum Zitat Barnett PG, Hamlett-Berry K, Sung HY, Max W. Healthcare expenditures attributable to smoking in military veterans. Nicotine Tob Res. 2015;17(5):586–91.CrossRefPubMed Barnett PG, Hamlett-Berry K, Sung HY, Max W. Healthcare expenditures attributable to smoking in military veterans. Nicotine Tob Res. 2015;17(5):586–91.CrossRefPubMed
8.
Zurück zum Zitat Larson GE, Booth-Kewley S, Ryan MA. Tobacco smoking as an index of military personnel quality. Mil Psychol. 2007;19(4):273–87.CrossRef Larson GE, Booth-Kewley S, Ryan MA. Tobacco smoking as an index of military personnel quality. Mil Psychol. 2007;19(4):273–87.CrossRef
9.
Zurück zum Zitat Macera CA, Aralis HJ, MacGregor AJ, Rauh MJ, Han PP, Galameau MR. Cigarette smoking, body mass index, and physical fitness changes among male navy personnel. Nicotine Tob Res. 2011;13(10):965–71.CrossRefPubMed Macera CA, Aralis HJ, MacGregor AJ, Rauh MJ, Han PP, Galameau MR. Cigarette smoking, body mass index, and physical fitness changes among male navy personnel. Nicotine Tob Res. 2011;13(10):965–71.CrossRefPubMed
10.
Zurück zum Zitat Woodruff SI, Conway TL, Shillington AM, Clapp JD, Lemus H, Reed MB. Cigarette smoking and subsequent hospitalizations in a cohort of young US Navy female recruits. Nicotine Tob Res. 2010;12(4):365–73.CrossRefPubMed Woodruff SI, Conway TL, Shillington AM, Clapp JD, Lemus H, Reed MB. Cigarette smoking and subsequent hospitalizations in a cohort of young US Navy female recruits. Nicotine Tob Res. 2010;12(4):365–73.CrossRefPubMed
11.
Zurück zum Zitat Smith EA, Jahnke SA, Poston WS, Williams LN, Haddock CK, Schroeder SA, Malone RE. Is it time for a tobacco-free military? N Engl J Med. 2014;371(7):589–91.CrossRefPubMedPubMedCentral Smith EA, Jahnke SA, Poston WS, Williams LN, Haddock CK, Schroeder SA, Malone RE. Is it time for a tobacco-free military? N Engl J Med. 2014;371(7):589–91.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Yang W, Dall TM, Zhang Y, Zhang S, Arday DR, Dom PW, Jain A. Simulation of quitting smoking in the military shows higher lifetime medical spending more than offset by productivity gains. Health Aff. 2012;31(12):2717–26.CrossRef Yang W, Dall TM, Zhang Y, Zhang S, Arday DR, Dom PW, Jain A. Simulation of quitting smoking in the military shows higher lifetime medical spending more than offset by productivity gains. Health Aff. 2012;31(12):2717–26.CrossRef
13.
Zurück zum Zitat Institute of Medicine. Combating tobacco use in military and veteran populations. Washington, DC: National Academies Press; 2009. Institute of Medicine. Combating tobacco use in military and veteran populations. Washington, DC: National Academies Press; 2009.
14.
Zurück zum Zitat Barlas FM, Higgins WB, Pflieger JC, Diecker K. 2011 Department of defense health related behaviors survey of active duty military personnel. U.S. Department of Defense, TRICARE Management Activity, Defense Health Cost Assessment and Program Evaluation, and the United States Coast Guard 2013. Barlas FM, Higgins WB, Pflieger JC, Diecker K. 2011 Department of defense health related behaviors survey of active duty military personnel. U.S. Department of Defense, TRICARE Management Activity, Defense Health Cost Assessment and Program Evaluation, and the United States Coast Guard 2013.
16.
Zurück zum Zitat Bray RM, Pemberton MR, Hourani LL, et al. Department of Defense survey of health related behaviors among active duty military personal. Research Triangle Park: RTI International; 2008; 2009. Bray RM, Pemberton MR, Hourani LL, et al. Department of Defense survey of health related behaviors among active duty military personal. Research Triangle Park: RTI International; 2008; 2009.
17.
Zurück zum Zitat Vander W, Mark W, Mengeling MA, et al. Prevalence and correlates of cigarette smoking among operation Iraqi Freedom-era and Operation Enduring Freedom-era women from the active component military and reserve/national guard. Med Care. 2015;53:55–62.CrossRef Vander W, Mark W, Mengeling MA, et al. Prevalence and correlates of cigarette smoking among operation Iraqi Freedom-era and Operation Enduring Freedom-era women from the active component military and reserve/national guard. Med Care. 2015;53:55–62.CrossRef
18.
Zurück zum Zitat Hurtado SL, Conway TL. Changes in smoking prevalence following a strict no-smoking policy in U.S. Navy recruit training. Mil Med. 1996;161(10):571–6.PubMed Hurtado SL, Conway TL. Changes in smoking prevalence following a strict no-smoking policy in U.S. Navy recruit training. Mil Med. 1996;161(10):571–6.PubMed
19.
Zurück zum Zitat Jahnke SA, Hoffman KM, Haddock CK, Long MA, Williams LN, Lando HA, Poston WS. Military tobacco policies: the good, the bad, and the ugly. Mil Med. 2011;176(12):1382–7.CrossRefPubMedPubMedCentral Jahnke SA, Hoffman KM, Haddock CK, Long MA, Williams LN, Lando HA, Poston WS. Military tobacco policies: the good, the bad, and the ugly. Mil Med. 2011;176(12):1382–7.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat U.S. Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012. U.S. Department of Health and Human Services. Preventing tobacco use among youth and young adults: a report of the surgeon general. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012.
21.
Zurück zum Zitat •• Siu AL, U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163:622. This report provides the latest evidence based recommendations for tobacco cessation and treating nicotine dependence with pharmacotherapy and behavioral interventions.CrossRefPubMed •• Siu AL, U.S. Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, Including Pregnant Women: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015;163:622. This report provides the latest evidence based recommendations for tobacco cessation and treating nicotine dependence with pharmacotherapy and behavioral interventions.CrossRefPubMed
22.
Zurück zum Zitat Patnode CP, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force. Evidence Synthesis No. 134. AHRQ Publication No. 14–05200-EF-1. Rockville: Agency for Healthcare Research and Quality; 2015. Patnode CP, Henderson JT, Thompson JH, Senger CA, Fortmann SP, Whitlock EP. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force. Evidence Synthesis No. 134. AHRQ Publication No. 14–05200-EF-1. Rockville: Agency for Healthcare Research and Quality; 2015.
23.
Zurück zum Zitat Fiore MC, Jaen CR, Baker TB. Clinical practice guideline—treating tobacco use and dependence: 2008 update. Rockville: U.S. Department of Health and Human Services; 2008. Fiore MC, Jaen CR, Baker TB. Clinical practice guideline—treating tobacco use and dependence: 2008 update. Rockville: U.S. Department of Health and Human Services; 2008.
24.
Zurück zum Zitat Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Intern Med. 1999;159(17):2033. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Intern Med. 1999;159(17):2033.
25.
Zurück zum Zitat •• Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013. A meta-analysis of 267 studies and more than 100,000 participants of the effectiveness of bupropion, nicotine replacement therapy, and varenicline for tobacco cessation. This represents a large comprehensive review of FDA approved tobacco cessation pharmacotherapy. •• Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013. A meta-analysis of 267 studies and more than 100,000 participants of the effectiveness of bupropion, nicotine replacement therapy, and varenicline for tobacco cessation. This represents a large comprehensive review of FDA approved tobacco cessation pharmacotherapy.
26.
Zurück zum Zitat Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC. Effects of nicotine patch vs. varenicline vs. combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial. JAMA. 2016;315(4):371–9.CrossRefPubMedPubMedCentral Baker TB, Piper ME, Stein JH, Smith SS, Bolt DM, Fraser DL, Fiore MC. Effects of nicotine patch vs. varenicline vs. combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial. JAMA. 2016;315(4):371–9.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195.CrossRefPubMed Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, Dale LC, Khayrallah MA, Schroeder DR, Glover PN, Sullivan CR, Croghan IT, Sullivan PM. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med. 1997;337(17):1195.CrossRefPubMed
28.
Zurück zum Zitat Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014.
29.
Zurück zum Zitat Thomas KH, Martin RM, Knipe DW, Higgins JP, Gunnell D. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ. 2015;350:h1109.CrossRefPubMedPubMedCentral Thomas KH, Martin RM, Knipe DW, Higgins JP, Gunnell D. Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis. BMJ. 2015;350:h1109.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Molero Y, Lichtenstein P, Zetterqvist J, Gumpert CH, Fazel S. Varenicline and risk of psychiatric conditions, suicidal behavior, criminal offending, and transport accidents and offences: population based cohort study. BMJ. 2015;350:h2388.CrossRefPubMedPubMedCentral Molero Y, Lichtenstein P, Zetterqvist J, Gumpert CH, Fazel S. Varenicline and risk of psychiatric conditions, suicidal behavior, criminal offending, and transport accidents and offences: population based cohort study. BMJ. 2015;350:h2388.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat •• Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387:2507–20. This study is randomized placebo controlled trial of pharmacotherapy for tobacco cessation in patient with and without psychiatric disorders. It represents the strongest evidence to date for the relative safety of varenicline and bupropion use in patients with and without psychiatric disorders.CrossRefPubMed •• Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387:2507–20. This study is randomized placebo controlled trial of pharmacotherapy for tobacco cessation in patient with and without psychiatric disorders. It represents the strongest evidence to date for the relative safety of varenicline and bupropion use in patients with and without psychiatric disorders.CrossRefPubMed
32.
Zurück zum Zitat Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221.CrossRefPubMedPubMedCentral Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S. Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial. Circulation. 2010;121(2):221.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012;344:e2856.CrossRefPubMedPubMedCentral Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis. BMJ. 2012;344:e2856.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Goodman J. Tobacco history and culture: an encyclopedia. Detroit: Scribner’s; 2005. Goodman J. Tobacco history and culture: an encyclopedia. Detroit: Scribner’s; 2005.
35.
Zurück zum Zitat PPG-TAB A: Amplification of the minimal standards of fitness for deployment to the CENTCOM AOR; to accompany MOD Eleven to USCENTCOM individual protection and individual/unit deployment policy. Section 15.C. PPG-TAB A: Amplification of the minimal standards of fitness for deployment to the CENTCOM AOR; to accompany MOD Eleven to USCENTCOM individual protection and individual/unit deployment policy. Section 15.C.
Metadaten
Titel
Tobacco Cessation in the Military
verfasst von
Tyson J. Sjulin
Jackie A. Hayes
Deborah E. Bray
Publikationsdatum
31.05.2017
Verlag
Springer US
Erschienen in
Current Pulmonology Reports / Ausgabe 3/2017
Elektronische ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-017-0185-9

Weitere Artikel der Ausgabe 3/2017

Airway Management in Combat Trauma

  • Pulmonology in Combat Medicine (G Eapen, Section Editor)

The Right Ventricle in Cardiorespiratory Failure

  • Point of Care Thoracic Ultrasound (S Koenig, Section Editor)

Diagnosis of Deep Venous Thrombosis at the Point-of-Care

  • Point of Care Thoracic Ultrasound (S Koenig, Section Editor)

Ultrasound Guidance for Thoracic Procedures

  • Point of Care Thoracic Ultrasound (S Koenig, Section Editor)

Assessment of Left Ventricular Function in the Critically Ill Patient

  • Point of Care Thoracic Ultrasound (S Koenig, Section Editor)

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Metastasiertes CRC: besser Checkpointhemmer im Doppelpack!

Die Kombination von Nivolumab plus Ipilimumab ist beim metastasierten Kolorektalkarzinom mit MSI-H- oder dMMR klar im Vorteil gegenüber einer Nivolumab-Monotherapie: Das Progressionsrisiko war damit in einer Phase-3-Studie um 38% reduziert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Die Riesenzellarteriitis (RZA) erfordert eine rasche und präzise Diagnose, da innerhalb weniger Tage ein schwerer, irreversibler Sehverlust drohen kann. In diesem Zusammenhang scheint die bilaterale Biopsie der Temporalarterien (TAB) der unilateralen überlegen zu sein.

Große Trinkmengen bei Blasentumoren möglicherweise von Nachteil

Beim nicht-muskelinvasiven Blasenkrebs scheint eine hohe Flüssigkeitszufuhr keinen schützenden Effekt in Bezug auf das Risiko eines Rezidivs oder einer Krankheitsprogression zu haben. Eine niederländische Studie legt sogar nahe, dass große Trinkmengen das Fortschreiten der Erkrankung begünstigen könnten.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.